Informatie:
Fout:
ID
39200
Beschrijving
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01122251
Link
https://clinicaltrials.gov/show/NCT01122251
Trefwoorden
Versies (1)
- 09-12-19 09-12-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
9 december 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Essential Hypertension NCT01122251
Eligibility Essential Hypertension NCT01122251
- StudyEvent: Eligibility
Similar models
Eligibility Essential Hypertension NCT01122251
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Age
Item
patients aged between 20 and 75
boolean
C0001779 (UMLS CUI [1])
Essential Hypertension Screening
Item
essential hypertension at screening (-3 week)
boolean
C0085580 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
C0220908 (UMLS CUI [1,2])
Randomization criteria
Item
randomization criteria:
boolean
C0034656 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,2])
Essential Hypertension Baseline | Sitting diastolic blood pressure | Exception Sitting systolic blood pressure
Item
essential hypertension at baseline (90mmhg≤sitdbp≤109mmhg, except sitsbp≥180)
boolean
C0085580 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1319893 (UMLS CUI [3,2])
C1442488 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1319893 (UMLS CUI [3,2])
Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
mean sitdbp≥110mmhg or sitsbp≥180
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C0444504 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Secondary hypertension | Secondary hypertension Suspected
Item
secondary hypertension or suspected secondary hypertension
boolean
C0155616 (UMLS CUI [1])
C0155616 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0155616 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Diabetic - poor control
Item
uncontrolled diabetes
boolean
C0421258 (UMLS CUI [1])
Heart Disease Severe | Cerebrovascular Disorder Severe
Item
severe heart disease or severe cerebrovascular disease
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0007820 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0205082 (UMLS CUI [1,2])
C0007820 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Hematologic Test Clinical Significance | Kidney Disease | Creatinine measurement, serum | Liver disease | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
clinically significant hematological test results, renal disease (serum creatinine) or liver disease (alt or ast)
boolean
C0018941 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0201836 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C2826293 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0201836 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
Malignant disease
Item
history of malignant disease
boolean
C0442867 (UMLS CUI [1])
Autoimmune Disease
Item
autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Pregnancy test positive | Breast Feeding | Pregnancy intended
Item
women with a positive pregnancy test result, breast feeding or intention of pregnancy during the trial
boolean
C0240802 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])